TAVI / TAVR in Shanghai: No Open-Heart Surgery for Aortic Valve Disease — Complete 2026 Guide
How Shanghai's leading cardiac centers are replacing diseased aortic valves through a catheter — no sternotomy, no heart-lung bypass, no months of recovery — for high-risk and elderly patients who cannot tolerate open surgery.
❤️ The Problem: Severe Aortic Stenosis
Aortic stenosis — the narrowing of the aortic valve opening — is the most common serious heart valve disease in adults over 65. Without treatment, severe aortic stenosis carries a 50% mortality rate within 2 years of symptom onset. For decades, the only treatment was open-heart surgery. For elderly or high-risk patients, that surgery carried unacceptable risk. TAVI changed everything.
TAVI (Transcatheter Aortic Valve Implantation), also called TAVR (Transcatheter Aortic Valve Replacement) in North America, delivers a new valve to the heart via a catheter threaded through the femoral artery in the groin. The procedure takes 1–2 hours. Most patients walk the next day and go home within 3–5 days.
🏥 Shanghai's Leading TAVI Centers
Zhongshan Hospital (中山医院)
Affiliation: Fudan University
Department: Department of Cardiology / Structural Heart Disease Center
TAVI Volume: 300+ cases annually (top 3 in China)
Valves Used: Venus-A (domestic), Evolut Pro (Medtronic), SAPIEN 3 (Edwards)
Highlight: National pioneer in TAVI; Prof. Ge Junbo's team performed some of China's earliest TAVI cases; active in China TAVI registry and international trials
Ruijin Hospital (瑞金医院)
Affiliation: Shanghai Jiao Tong University School of Medicine
Department: Department of Cardiology
TAVI Volume: 200+ cases annually
Valves Used: Venus-A, VitaFlow (MicroPort), Evolut Pro
Highlight: Strong in complex TAVI cases (bicuspid aortic valve, heavily calcified annuli); integrated cardiac imaging team for pre-procedural CT planning
Shanghai Chest Hospital (市胸科医院)
Affiliation: Shanghai Jiao Tong University
Department: Structural Heart Disease Center
TAVI Volume: 150+ cases annually
Valves Used: VitaFlow, Venus-A, SAPIEN 3
Highlight: Specializes in high-surgical-risk patients; multidisciplinary heart team (cardiac surgery + interventional cardiology) reviews every case
🔬 TAVI vs. Open Aortic Valve Replacement (SAVR): Key Differences
| Feature | Open Surgery (SAVR) | TAVI / TAVR |
|---|---|---|
| Incision | Full sternotomy (chest opened) | Small groin puncture (catheter-based) |
| Heart-lung bypass | ❌ Required | ✅ Not required |
| General anesthesia | Required | Often local + sedation only |
| Hospital stay | 7–14 days | 3–5 days |
| Full recovery | 3–6 months | 2–4 weeks |
| 30-day mortality (high-risk patients) | 5–10% | 2–3% |
| Suitable for frail/elderly patients | ❌ Often too high risk | ✅ Specifically designed for this group |
👤 Who Is a Candidate for TAVI in Shanghai?
✅ Strong Candidates
- Severe symptomatic aortic stenosis (AVA <1.0 cm²)
- Age 75+ with high surgical risk (STS score >4%)
- Intermediate surgical risk patients preferring minimally invasive approach
- Patients with prior cardiac surgery (redo cases)
- Frail patients with multiple comorbidities (COPD, renal failure, prior stroke)
- Bicuspid aortic valve (selected cases at experienced centers)
❌ Less Suitable / Requires Discussion
- Young patients (<65) with low surgical risk — open surgery may offer longer valve durability
- Severe aortic regurgitation (TAVI less established)
- Anatomically unfavorable annulus size or vascular access
- Active endocarditis
🇨🇳 China's Domestic TAVI Valves: A Competitive Advantage
China has developed its own TAVI valve systems, approved by the NMPA (National Medical Products Administration), which significantly reduce costs compared to imported devices:
Venus-A (天源医疗)
China's first approved TAVI valve (2017). Self-expanding, repositionable. Used in 10,000+ cases across China. Strong evidence base.
VitaFlow (MicroPort, Shanghai)
Manufactured in Shanghai. Self-expanding with recapture capability. Approved 2019. Particularly suited for bicuspid valves and complex anatomy.
Evolut Pro (Medtronic, USA)
Imported. Gold standard globally. Available at top Shanghai centers for cases requiring specific sizing or anatomy.
SAPIEN 3 (Edwards, USA)
Imported. Balloon-expandable. Preferred for certain anatomies. Available at Zhongshan and Ruijin.
💰 Cost of TAVI in Shanghai vs. International Comparison
| Cost Component | Shanghai (USD) | USA (USD) | Germany (USD) |
|---|---|---|---|
| TAVI with domestic valve (Venus-A / VitaFlow) | $18,000–28,000 | $80,000–$150,000 | $45,000–70,000 |
| TAVI with imported valve (Evolut / SAPIEN 3) | $30,000–45,000 | $80,000–$150,000 | $45,000–70,000 |
*Estimates include procedure, valve device, hospital stay (3–5 days), and standard post-procedure care. Contact CMCS for a personalized quote based on your specific case.
✅ The Shanghai Advantage
TAVI with a domestic valve in Shanghai costs 4–6x less than the US and 2–3x less than Germany, performed by teams with equivalent or higher case volumes than most Western centers. Zhongshan Hospital's structural heart team has performed more TAVI cases than most European centers.
🏥 How CMCS Arranges Your TAVI in Shanghai
TAVI requires careful pre-procedural planning including cardiac CT, echocardiography, and multidisciplinary heart team review. China Medical Concierge Shanghai (CMCS) coordinates every step for international patients, from initial case review to post-discharge follow-up.
CMCS Services for TAVI Patients:
- ✅ Pre-arrival cardiac case review (echocardiogram, CT reports reviewed)
- ✅ TAVI eligibility assessment and heart team referral
- ✅ Interventional cardiologist appointment at Zhongshan, Ruijin, or Shanghai Chest Hospital
- ✅ Medical record and imaging translation (DICOM files accepted)
- ✅ Pre-procedural CT angiography coordination
- ✅ Valve selection guidance (domestic vs. imported)
- ✅ Medical visa support (S1/S2)
- ✅ Airport transfers and hospital-adjacent accommodation
- ✅ On-site interpretation during all consultations and procedure day
- ✅ Post-discharge cardiac rehabilitation coordination
- ✅ Remote follow-up with echocardiogram coordination at 30 days and 1 year
📞 Contact CMCS:
📧 Email: contract@medicalsh.com
📱 Phone/WhatsApp: +86 170 6215 3332
💬 WeChat: gezhanglao
🌐 Website: medicalsh.com
Key Takeaways
- TAVI replaces the aortic valve without open-heart surgery — catheter through the groin, home in 3–5 days.
- Shanghai leads China in TAVI volume — Zhongshan, Ruijin, and Shanghai Chest Hospital perform 600+ cases annually combined.
- Domestic valves (Venus-A, VitaFlow) offer major cost savings with strong clinical evidence.
- Best for: Elderly or high-risk patients with severe aortic stenosis who cannot tolerate open surgery.
- Cost advantage: 4–6x cheaper than the US, 2–3x cheaper than Germany.
- CMCS manages everything — from cardiac CT coordination to post-discharge follow-up.
References
- Zhongshan Hospital Fudan University — Structural Heart Disease Center, TAVI Program
- Ruijin Hospital — Department of Cardiology, Structural Heart Disease Team
- Shanghai Chest Hospital — Structural Heart Disease Center
- Venus MedTech — Venus-A Clinical Data
- MicroPort — VitaFlow TAVI System (Shanghai)
- China Medical Concierge Shanghai — medicalsh.com
For international patients seeking TAVI in Shanghai, CMCS provides end-to-end cardiac concierge support. Contact us today to begin your assessment.
댓글 0개